GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Solventum Corp (MEX:SOLV) » Definitions » Total Liabilities

Solventum (MEX:SOLV) Total Liabilities : MXN239,799 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Solventum Total Liabilities?

Solventum's Total Liabilities for the quarter that ended in Dec. 2024 was MXN239,799 Mil.

Solventum's quarterly Total Liabilities increased from Jun. 2024 (MXN214,546.73 Mil) to Sep. 2024 (MXN227,482.04 Mil) and increased from Sep. 2024 (MXN227,482.04 Mil) to Dec. 2024 (MXN239,798.84 Mil).

Solventum's annual Total Liabilities increased from Dec. 2022 (MXN36,106.59 Mil) to Dec. 2023 (MXN38,650.36 Mil) and increased from Dec. 2023 (MXN38,650.36 Mil) to Dec. 2024 (MXN239,798.84 Mil).


Solventum Total Liabilities Historical Data

The historical data trend for Solventum's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solventum Total Liabilities Chart

Solventum Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
- 41,356.22 36,106.59 38,650.36 239,798.84

Solventum Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38,650.36 180,235.33 214,546.73 227,482.04 239,798.84

Solventum Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Solventum's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=56372.957+(162883.017+8550.837
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+4692.532+7299.495+0)
=239,799

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=301510.855-61712.016
=239,799

Solventum's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=56372.957+(162883.017+8550.837
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+4692.532+7299.495+0)
=239,799

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=301510.855-61712.016
=239,799

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Solventum Total Liabilities Related Terms

Thank you for viewing the detailed overview of Solventum's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Solventum Business Description

Traded in Other Exchanges
Address
2510 Conway Avenue East, 3M Center, Building 275-6W, Maplewood, MN, USA, 55144
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.